Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,173 JPY | +1.88% | +0.94% | +2.94% |
May. 31 | Takeda Pharmaceutical Says Recombinant ADAMTS13 Gets Approval Recommendation From European Medicines Agency's CHPM | MT |
May. 31 | Takeda Gets CHMP Approval for Recombinant ADAMTS13 | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.94% | 41.02B | |
+40.73% | 734B | |
+32.83% | 591B | |
-6.30% | 350B | |
+15.15% | 315B | |
+4.05% | 276B | |
+15.00% | 238B | |
+9.78% | 206B | |
-5.52% | 204B | |
+6.17% | 161B |
- Stock Market
- Equities
- 4502 Stock
- News Takeda Pharmaceutical Company Limited
- Takeda Canada Completes LOI Stage for Post-Transplant Cytomegalovirus Treatment